Laboratorios Farmaceuticos ROVI SA
F:41L
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Laboratorios Farmaceuticos ROVI SA
F:41L
|
ES |
|
DMG Mori Co Ltd
F:0MO
|
JP |
|
Evonik Industries AG
F:EVKA
|
DE |
|
Reconnaissance Energy (Africa) Ltd
F:0XD
|
CA |
|
Z
|
Zymeworks Inc
F:ZA8
|
US |
|
C
|
Clearway Energy Inc
F:NY41
|
US |
|
A
|
Aspen Aerogels Inc
F:AP1
|
US |
|
E
|
Evonik Industries AG
XMUN:EVK
|
DE |
|
E
|
Evolent Health Inc
F:9EH
|
US |
|
N
|
Nippon Steel Corp
F:NPS
|
JP |
|
Lisata Therapeutics Inc
F:8NE
|
US |
|
Fresh Del Monte Produce Inc
NYSE:DMC
|
KY |
|
O
|
Ossia International Ltd
SGX:O08
|
SG |
|
Saga Communications Inc
F:SGHB
|
US |
|
C
|
CNO Financial Group Inc
F:COS
|
US |
|
N
|
Nippon Steel Corp
XMUN:NPS
|
JP |
|
B
|
Broadstone Net Lease Inc
F:62XA
|
US |
|
P
|
Pandora A/S
XMUN:3P7
|
DK |
|
P
|
Pandora A/S
OTC:PANDY
|
DK |
|
E
|
Evonik Industries AG
SWB:EVK
|
DE |
|
N
|
Nippon Steel Corp
DUS:NPS
|
JP |
|
Stevva Corp
OTC:STVA
|
GR |
|
E
|
Evonik Industries AG
F:EVK
|
DE |
|
D
|
DMG Mori Co Ltd
SWB:0MO
|
JP |
Wall St Price Targets
41L Price Targets Summary
Laboratorios Farmaceuticos ROVI SA
According to Wall Street analysts, the average 1-year price target for 41L is 89.65 EUR with a low forecast of 71.3 EUR and a high forecast of 115.46 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 41L's stock price target?
Price Target
89.65
EUR
According to Wall Street analysts, the average 1-year price target for 41L is 89.65 EUR with a low forecast of 71.3 EUR and a high forecast of 115.46 EUR.
What is the Revenue forecast for Laboratorios Farmaceuticos ROVI SA?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 5 years is 9%.
What is the Gross Profit forecast for Laboratorios Farmaceuticos ROVI SA?
Projected CAGR
12%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 5 years is 12%.
What is the Operating Income forecast for Laboratorios Farmaceuticos ROVI SA?
Projected CAGR
16%
Over the last 14 years, the compound annual growth rate for Operating Income has been 18%. The projected CAGR for the next 5 years is 16%.
What is the Pre-Tax Income forecast for Laboratorios Farmaceuticos ROVI SA?
Projected CAGR
20%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 18%. The projected CAGR for the next 3 years is 20%.
What is the Net Income forecast for Laboratorios Farmaceuticos ROVI SA?
Projected CAGR
15%
Over the last 14 years, the compound annual growth rate for Net Income has been 16%. The projected CAGR for the next 5 years is 15%.
